Physician profile
Wayne H Martin
NPI 1033293261
$5,683.12
in general payments reported to CMS, 2019-2025
24 companies · $1,175 in 2025
The $1,175 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,131 · 2020: $872 · 2021: $921 · 2022: $678 · 2023: $412 · 2024: $495 · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,056 · Entertainment: $25.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,056.26 |
| Entertainment | $25.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $952.70 | 2019-2025 | |
| Alcon Vision LLC | $678.01 | 2019-2025 | Clareon, Rocklatan, Tryptyr |
| Allergan, INC. | $656.39 | 2019-2022 | |
| Dompe US, INC. | $451.11 | 2021-2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $427.58 | 2019-2021 | |
| Amgen INC. | $295.28 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $235.04 | 2022-2025 | Miebo, Amvisc, Envista Mx60 Iol |
| Mallinckrodt Hospital Products INC. | $220.48 | 2021-2023 | Acthar |
| Novartis Pharmaceuticals Corporation | $220.11 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $210.63 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $180.72 | 2019-2022 | |
| Horizon Therapeutics Plc | $164.69 | 2022-2023 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $164.54 | 2019-2024 | Lipiflow System Activator (Disposable) |
| Eyevance Pharmaceuticals LLC | $148.31 | 2019-2022 | |
| Rxsight INC | $117.07 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $109.10 | 2025 | Vevye |
| Janssen Pharmaceuticals, INC | $105.84 | 2019 | |
| Abbvie INC. | $98.60 | 2022-2025 | |
| Optos, INC. | $68.84 | 2022-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $53.59 | 2022-2024 | Tyrvaya |
| Thea Pharma INC. | $47.96 | 2024 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $38.92 | 2024 | Xdemvy |
| Shire North American Group INC | $25.44 | 2019 | |
| Sight Sciences, INC. | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.